| Human |
hsa_circ_XPO1 |
hsa_circ_0001016 |
circXPO1 |
lung adenocarcinoma |
XPO1 |
- |
Q
S
| UP |
More |
| Human |
hsa_circ_XPO1 |
hsa_circ_0005050 |
- |
oral cavity squamous cell carcinoma |
XPO1 |
- |
Q
S
| UN |
More |
| Human |
hsa_circ_XPO1 |
hsa_circ_0001016 |
circXPO1 |
prostate cancer |
XPO1 |
miR-23a |
Q
| UP |
More |
| Human |
hsa_circ_XPO1 |
- |
hsa_circRNA_102736 |
osteosarcoma |
XPO1 |
miR-23a-3p, miR-23b-3p, miR-23c, miR-130a-5p |
Q
M
| UP |
More |
| Human |
hsa_circ_XPO1 |
hsa_circ_0001017 |
circ_0001017 |
gastric cancer |
XPO1 |
miR-543 |
Q
| DN |
More |
| Human |
hsa_circ_XPO1 |
hsa_circ_0005050 |
Circ_0005050 |
oral cavity squamous cell carcinoma |
XPO1 |
miR-23a-3p, miR-625-5p |
Q
| UP |
More |
| Human |
hsa_circ_XPO1 |
hsa_circ_0005050 |
circXPO1 |
oral cavity squamous cell carcinoma |
- |
miR-524-5p |
Q
| UP |
More |
| Human |
hsa_circ_XPO1 |
hsa_circ_0001017 |
circXPO1 |
gastric cancer |
XPO1 |
miR-1248 |
Q
S
| UP |
More |
| Human |
hsa_circ_XPO1 |
hsa_circ_0005050 |
circ_0005050 |
oral cavity squamous cell carcinoma |
XPO1 |
miR-487a-3p |
Q
| UP |
More |
| Human |
hsa_circ_XPO1 |
- |
circXPO1 / hsa_circ_102737 |
glioblastoma |
XPO1 |
miR-7-5p |
Q
M
| UP |
More |
| Human |
hsa_circ_XPO1 |
- |
hsa_circRNA_102735 / circXPO1 |
plasma cell myeloma |
XPO1 |
miR-495-3p |
Q
M
| UP |
More |
| Human |
hsa_circ_XPO1 |
hsa_circ_0001017 |
circXPO1 |
colorectal cancer |
XPO1 |
- |
Q
| UP |
More |
| Human |
hsa_circ_XPO1 |
- |
circXPO1-2 |
colorectal cancer |
XPO1 |
- |
Q
S
| DN |
More |
| Human |
hsa_circ_XPO1 |
hsa_circ_0001017 |
circXPO1 |
amyotrophic lateral sclerosis |
XPO1 |
- |
Q
| DS |
More |
| Human |
hsa_circ_XPO1 |
hsa_circ_0001016 |
- |
chronic obstructive pulmonary disease |
XPO1 |
miR-23b-3p |
Q
| UP |
More |